Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

LITTLE ROCK, Ark. and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.

Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences

BATON ROUGE, La. and NASHVILLE, Tenn., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Amedisys is recognized as one of the most responsible companies in the nation, according to a report by Statista in the latest issue of Newsweek magazine. The recognition is based on key performance indicators derived from the company's corporate social responsibility and sustainability report and includes performance in the areas of environment, social and corporate governance.

Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek

BATON ROUGE, La., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer and Scott Ginn, Chief Operating Officer, will present at the Bank of American Securities Home Care Conference on Tuesday, December 6 at 9 a.m. ET.

Amedisys to Present at Bank of America Securities Home Care Conference

Company CEO departed last week, although management reaffirmed FY22 guidance. Speaking of guidance, growth at the top–bottom lines was narrowed down on the Q3 earnings call.

Amedisys: No Change To Thesis, Retain Hold

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately.

Amedisys Names Scott Ginn Acting Chief Operating Officer

BATON ROUGE, La. , Nov. 17, 2022 /PRNewswire/ -- Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022, and Paul Kusserow, Chair of the Board of Directors will take over as Chief Executive Officer until a new Chief Executive Officer is identified.

Amedisys Confirms Full Year Guidance

Paul Kusserow returns as Chairman and CEO BATON ROUGE, La. , Nov. 17, 2022 /PRNewswire/ -- Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022.

Amedisys Announces CEO Departure

BATON ROUGE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, issued the following statement following the CY 2023 Home Health Final Rule by the Centers for Medicare and Medicaid Services (CMS).

Amedisys Statement on CY 2023 Home Health Final Rule

Within Amedisys (AMED) Home Health and Hospice, the reinstatement of sequestration reduces growth in Q3.

Amedisys (AMED) Q3 Earnings Miss Estimates, Guidance Cut

Amedisys, Inc. (NASDAQ:AMED ) Q3 2022 Earnings Conference Call October 27, 2022 11:00 AM ET Company Participants Nick Muscato – Chief Strategy Officer Chris Gerard – President and Chief Executive Officer Scott Ginn – Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies Matt Larew – William Blair Justin Bowers – Deutsche Bank A.J. Rice – Credit Suisse Sarah James – Barclays Ben Hendrix – RBC Capital Markets Bill Sutherland – Benchmark Company John Ransom – Raymond James Scott Fidel – Stephens Whit Mayo – SVB Securities Tao Qiu – Stifel Andrew Mok – UBS Joanna Gajuk – Bank of America Operator Greetings.

Amedisys, Inc. (AMED) Q3 2022 Earnings Call Transcript

Amedisys (AMED) delivered earnings and revenue surprises of -7.26% and 3.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates

BATON ROUGE, La., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2022.

Amedisys Reports Third Quarter 2022 Financial Results and Updates 2022 Guidance

Addus HomeCare

Hanger Inc

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. AMED, ADUS and HNGR are well poised to gain from the prospects.

3 Stocks to Watch From the Pandemic-Hit Outpatient Home Health Industry

BATON ROUGE, La., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice, personal care and high-acuity care company, announced today that Adam Holton will join the Company as Chief People Officer.

Amedisys Welcomes Adam Holton as Chief People Officer

Investors are optimistic about Amedisys' (AMED) better-than-expected earnings and notable buyouts.

Here's Why Investors Should Retain Amedisys (AMED) Stock for Now

Mount Sinai at Home provides home health, hospitalization at home, rehabilitation at home and palliative care at home to patients in the New York metropolitan area Mount Sinai at Home provides home health, hospitalization at home, rehabilitation at home and palliative care at home to patients in the New York metropolitan area

Mount Sinai Health System Partners with Contessa to Create Mount Sinai at Home, a Home-Based Care Continuum

Lower utilization of home health benefit, primarily driven by lesser total discharges to post-acute settings, hampers Amedisys' (AMED) Q2 revenues.

Amedisys (AMED) Q2 Earnings Surpass Estimates, Margins Down

Amedisys Inc (NASDAQ:AMED ) Q2 2022 Earnings Conference Call July 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Chris Gerard - President and Chief Executive Officer Scott Ginn - Executive Vice President and Chief Financial Officer David Kemmerly - Chief Legal and Government Affairs Officer Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair Justin Bowers - Deutsche Bank John Ransom - Raymond James Benjamin Rossi - BMO Sarah James - Barclays A.J. Rice - Crédit Suisse Michael Murray - RBC Andrew Mok - UBS Tao Qiu - Stifel Scott Fidel - Stephens Whit Mayo - SVB Securities Nabil Gutierrez - BofA Securities Operator Greetings.

Amedisys Inc (AMED) CEO Chris Gerard on Q2 2022 Results - Earnings Call Transcript

Amedisys (AMED) delivered earnings and revenue surprises of 19.51% and 4.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Q2 Earnings Beat Estimates

BATON ROUGE, La., July 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2022.

Amedisys Reports Second Quarter 2022 Financial Results and Updates 2022 Revenue Guidance

BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 28, 2022.

Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date

Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.

Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care

This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative care This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative care

Memorial Hermann and Contessa Partner to Provide Patients New At-Home Care Options

Amedisys' (AMED) latest initiative aims at providing patients with a high-quality continuum of care in the home.

Amedisys (AMED) Contessa's New JV Broadens At-Home Care Range

Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomes Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomes

News for Amedisys Stock (AMED)